2021
Misreporting of Results of Research in Psychiatry
Bowcut J, Levi L, Livnah O, Ross JS, Knable M, Davidson M, Davis JM, Weiser M. Misreporting of Results of Research in Psychiatry. Schizophrenia Bulletin 2021, 47: 1254-1260. PMID: 33860793, PMCID: PMC8379531, DOI: 10.1093/schbul/sbab040.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchData Interpretation, StatisticalHumansOutcome Assessment, Health CarePsychiatryPublication BiasRandomized Controlled Trials as TopicResearch Design
2019
Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews
Liu P, Ross JS, Ioannidis JP, Dhruva SS, Vasiliou V, Wallach JD. Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews. Clinical Trials 2019, 17: 231-234. PMID: 31709809, DOI: 10.1177/1740774519887148.Peer-Reviewed Original ResearchAge-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study
Liu P, Ioannidis JPA, Ross JS, Dhruva SS, Luxkaranayagam AT, Vasiliou V, Wallach JD. Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study. BMC Medicine 2019, 17: 188. PMID: 31639007, PMCID: PMC6805640, DOI: 10.1186/s12916-019-1420-8.Peer-Reviewed Original ResearchConceptsCochrane intervention reviewsFormal interaction testingSubgroup analysisIntervention reviewsClinical practice resourcesInsufficient trial dataPotential subgroup differencesMeta-epidemiological studyIndividual subgroup analysisCochrane reviewAppropriate statistical testsClinical significanceClinical careSubgroup findingsTrial dataClinical resourcesHealthcare interventionsBiological rationaleAnalysis of ageTrialsIndividual trialsDemographic characteristicsPractice resourcesSubgroup differencesClinical translation
2018
Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators
Bates J, Parzynski CS, Dhruva SS, Coppi A, Kuntz R, Li S, Marinac‐Dabic D, Masoudi FA, Shaw RE, Warner F, Krumholz HM, Ross JS. Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators. Pharmacoepidemiology And Drug Safety 2018, 27: 848-856. PMID: 29896873, PMCID: PMC6436550, DOI: 10.1002/pds.4565.Peer-Reviewed Original ResearchConceptsAdverse event ratesSafety differencesEvent ratesMedical device utilizationICD utilizationRate ratioNational Cardiovascular Data RegistryICD modelsImplantable cardioverter defibrillatorEvent rate ratioMost patientsCardioverter defibrillatorProportion of individualsAmerican CollegeData registryRoutine surveillanceSample size estimatesAverage event rateDevice utilizationSignificance levelDifferencesPatientsRegistryDefibrillatorICD
2017
Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project
Low J, Ross JS, Ritchie JD, Gross CP, Lehman R, Lin H, Fu R, Stewart LA, Krumholz HM. Comparison of two independent systematic reviews of trials of recombinant human bone morphogenetic protein-2 (rhBMP-2): the Yale Open Data Access Medtronic Project. Systematic Reviews 2017, 6: 28. PMID: 28196521, PMCID: PMC5310069, DOI: 10.1186/s13643-017-0422-x.Peer-Reviewed Original ResearchConceptsParticipant-level dataSystematic reviewSummary estimatesRecombinant human bone morphogenetic protein-2Inclusion criteriaCenter BIndividual participant-level dataMeta-analysis inclusion criteriaHuman bone morphogenetic protein-2Trial inclusion criteriaMulti-site clinical trialMain outcome measuresMost clinical outcomesStatistical methodsConcurrent systematic reviewIndependent systematic reviewsProtein 2Bone morphogenetic protein-2Summary efficacyMorphogenetic protein-2Adverse eventsClinical outcomesSurgical approachTrial inclusionClinical trials
2015
Predictors and outcomes of unplanned readmission to a different hospital
Kim H, Hung WW, Paik MC, Ross JS, Zhao Z, Kim GS, Boockvar K. Predictors and outcomes of unplanned readmission to a different hospital. International Journal For Quality In Health Care 2015, 27: 513-519. PMID: 26472739, PMCID: PMC4665363, DOI: 10.1093/intqhc/mzv082.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCaliforniaData Interpretation, StatisticalDatasets as TopicFemaleForecastingHospitalsHumansMaleMiddle AgedOutcome Assessment, Health CarePatient DischargePatient ReadmissionConceptsDifferent-hospital readmissionsReadmission groupAcute care hospitalsDifferent hospitalsUnplanned readmissionCare hospitalSame hospitalThirty-day unplanned readmissionsPercent of patientsSame-hospital readmissionsBetter care coordinationHospital deathIndex dischargeIndex hospitalCare coordinationHospital costsReadmissionHigher oddsMAIN OUTCOMEPatientsHealth outcomesCost outcomesHospitalSecondary analysisOutcomes
2011
A Model for Dissemination and Independent Analysis of Industry Data
Krumholz HM, Ross JS. A Model for Dissemination and Independent Analysis of Industry Data. JAMA 2011, 306: 1593-1594. PMID: 21990302, PMCID: PMC3688082, DOI: 10.1001/jama.2011.1459.Commentaries, Editorials and Letters
2009
Use of Stroke Secondary Prevention Services
Ross JS, Halm EA, Bravata DM. Use of Stroke Secondary Prevention Services. Stroke 2009, 40: 1811-1819. PMID: 19265044, PMCID: PMC2768116, DOI: 10.1161/strokeaha.108.539619.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAspirinCross-Sectional StudiesData Interpretation, StatisticalDelivery of Health CareEthnicityFemaleGeographyHealth BehaviorHealth Care SurveysHealth StatusHealthcare DisparitiesHumansLife StyleMaleMiddle AgedPlatelet Aggregation InhibitorsRisk FactorsSex FactorsSocioeconomic FactorsStrokeUnited StatesYoung AdultConceptsSecondary prevention servicesOutpatient rehabilitationPrevention servicesRegular exerciseService useHealth care access characteristicsBehavior Risk Factor Surveillance SystemRisk Factor Surveillance SystemSmoking cessation counselingHistory of strokeMultivariable logistic regressionStroke Belt statesNon-Hispanic blacksOverall service useLow useState residenceSex-based differencesRace-based differencesPneumococcal vaccinationAntihypertensive medicationsCessation counselingStroke outcomeSelf-reported useAge 80Stroke Belt